Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Ambulatory Neuroproprioceptive Facilitation and Inhibition Physical Therapy Improves Clinical Outcomes in Multiple Sclerosis and Modulates Serum Level of Neuroactive Steroids: A Two-Arm Parallel-Group Exploratory Trial

G. Angelova, T. Skodova, T. Prokopiusova, M. Markova, N. Hruskova, M. Prochazkova, M. Pavlikova, S. Spanhelova, I. Stetkarova, M. Bicikova, L. Kolatorova, K. Rasova,

. 2020 ; 10 (11) : . [pub] 20201031

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21001859

Background: Only few studies have monitored the potential of physical activity training and physical therapy to modulate the reaction of the endocrine system. In this study, the effect of neuroproprioceptive facilitation and inhibition physical therapy on clinical outcomes and neuroactive steroids production in people with multiple sclerosis was evaluated. Moreover, we were interested in the factors that influence the treatment effect. METHODS: In total, 44 patients with multiple sclerosis were randomly divided into two groups. Each group underwent a different kind of two months ambulatory therapy (Motor program activating therapy and Vojta's reflex locomotion). During the following two months, participants were asked to continue the autotherapy. Primary (serum level of cortisol, cortisone, 7α-OH-DHEA, 7β-OH-DHEA, 7-oxo-DHEA, DHEA) and secondary (balance, cognition and patient-reported outcomes) outcomes were examined three times (pre, post, and washout assessments). RESULTS: In both groups, there is a decreasing trend of 7-oxo-DHEA concentration in post-assessment and 7β-OH-DHEA in washout versus pre-assessment. A higher impact on neuroactive steroids is visible after Vojta's reflex locomotion. As for clinical outcomes, the Paced Auditory Serial Addition Test and Multiple Sclerosis Impact Scale significantly improved between post-assessment and washout assessment. The improvement was similar for both treatments. CONCLUSIONS: Neuroproprioceptive facilitation and inhibition improved the clinical outcomes and led to non-significant changes in neuroactive steroids. Trial registration (NCT04379193).

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21001859
003      
CZ-PrNML
005      
20210126092731.0
007      
ta
008      
210105s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/life10110267 $2 doi
035    __
$a (PubMed)33142850
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Angelova, Gabriela $u Department of Rehabilitation Medicine, Third Faculty of Medicine, Charles University, Ruska 87, 10000 Prague 10, Czech Republic.
245    10
$a Ambulatory Neuroproprioceptive Facilitation and Inhibition Physical Therapy Improves Clinical Outcomes in Multiple Sclerosis and Modulates Serum Level of Neuroactive Steroids: A Two-Arm Parallel-Group Exploratory Trial. / $c G. Angelova, T. Skodova, T. Prokopiusova, M. Markova, N. Hruskova, M. Prochazkova, M. Pavlikova, S. Spanhelova, I. Stetkarova, M. Bicikova, L. Kolatorova, K. Rasova,
520    9_
$a Background: Only few studies have monitored the potential of physical activity training and physical therapy to modulate the reaction of the endocrine system. In this study, the effect of neuroproprioceptive facilitation and inhibition physical therapy on clinical outcomes and neuroactive steroids production in people with multiple sclerosis was evaluated. Moreover, we were interested in the factors that influence the treatment effect. METHODS: In total, 44 patients with multiple sclerosis were randomly divided into two groups. Each group underwent a different kind of two months ambulatory therapy (Motor program activating therapy and Vojta's reflex locomotion). During the following two months, participants were asked to continue the autotherapy. Primary (serum level of cortisol, cortisone, 7α-OH-DHEA, 7β-OH-DHEA, 7-oxo-DHEA, DHEA) and secondary (balance, cognition and patient-reported outcomes) outcomes were examined three times (pre, post, and washout assessments). RESULTS: In both groups, there is a decreasing trend of 7-oxo-DHEA concentration in post-assessment and 7β-OH-DHEA in washout versus pre-assessment. A higher impact on neuroactive steroids is visible after Vojta's reflex locomotion. As for clinical outcomes, the Paced Auditory Serial Addition Test and Multiple Sclerosis Impact Scale significantly improved between post-assessment and washout assessment. The improvement was similar for both treatments. CONCLUSIONS: Neuroproprioceptive facilitation and inhibition improved the clinical outcomes and led to non-significant changes in neuroactive steroids. Trial registration (NCT04379193).
655    _2
$a časopisecké články $7 D016428
700    1_
$a Skodova, Tereza $u Department of Steroids and Proteofactors, Institute of Endocrionology, 11694 Prague, Czech Republic.
700    1_
$a Prokopiusova, Terezie $u Department of Rehabilitation Medicine, Third Faculty of Medicine, Charles University, Ruska 87, 10000 Prague 10, Czech Republic.
700    1_
$a Markova, Magdalena $u Department of Rehabilitation Medicine, Third Faculty of Medicine, Charles University, Ruska 87, 10000 Prague 10, Czech Republic.
700    1_
$a Hruskova, Natalia $u Department of Rehabilitation Medicine, Third Faculty of Medicine, Charles University, Ruska 87, 10000 Prague 10, Czech Republic.
700    1_
$a Prochazkova, Marie $u Department of Rehabilitation Medicine, Third Faculty of Medicine, Charles University, Ruska 87, 10000 Prague 10, Czech Republic.
700    1_
$a Pavlikova, Marketa $u Department of Rehabilitation Medicine, Third Faculty of Medicine, Charles University, Ruska 87, 10000 Prague 10, Czech Republic.
700    1_
$a Spanhelova, Sarka $u Department of Rehabilitation and Sport Medicine, Motol University Hospital, V Uvalu 84, 150 06 Prague 5, Czech Republic.
700    1_
$a Stetkarova, Ivana $u Department of Neurology, Third Faculty of Medicine, Charles University, 10000 Prague, Czech Republic.
700    1_
$a Bicikova, Marie $u Department of Steroids and Proteofactors, Institute of Endocrionology, 11694 Prague, Czech Republic.
700    1_
$a Kolatorova, Lucie $u Department of Steroids and Proteofactors, Institute of Endocrionology, 11694 Prague, Czech Republic.
700    1_
$a Rasova, Kamila $u Department of Rehabilitation Medicine, Third Faculty of Medicine, Charles University, Ruska 87, 10000 Prague 10, Czech Republic.
773    0_
$w MED00186366 $t Life (Basel, Switzerland) $x 2075-1729 $g Roč. 10, č. 11 (2020)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33142850 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210126092727 $b ABA008
999    __
$a ind $b bmc $g 1614043 $s 1122143
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 10 $c 11 $e 20201031 $i 2075-1729 $m Life $n Life (Basel) $x MED00186366
LZP    __
$a Pubmed-20210105

Find record

Citation metrics

Archiving options